{
    "id": "wrong_mix_range_subsidiary_00043_3",
    "rank": 12,
    "data": {
        "url": "https://fprimecapital.com/portfolio",
        "read_more_link": "",
        "language": "en",
        "title": "Portfolio • F",
        "top_image": "https://fprimecapital.com/wp-content/uploads/2023/08/F-Prime-Site.png",
        "meta_img": "https://fprimecapital.com/wp-content/uploads/2023/08/F-Prime-Site.png",
        "images": [
            "https://fprimecapital.com/wp-content/uploads/2018/05/Beam-Therapeutics.svg",
            "https://fprimecapital.com/wp-content/uploads/2018/06/Benchling.svg",
            "https://fprimecapital.com/wp-content/uploads/2020/02/BenchSci.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/Blueprint.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/04/Caribou-Biosciences.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/05/Denali.svg",
            "https://fprimecapital.com/wp-content/uploads/2017/10/Devoted-Health.svg",
            "https://fprimecapital.com/wp-content/uploads/2021/02/Equip.svg",
            "https://fprimecapital.com/wp-content/uploads/2018/05/Farapulse.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/Flywire.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/FoldRx.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/FutureAdvisor.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/Innovent.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/iorahealth.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/Kensho.svg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/lighthouse-website.png",
            "https://fprimecapital.com/wp-content/uploads/2018/09/Notable.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/11/PatientPing.svg",
            "https://fprimecapital.com/wp-content/uploads/2021/07/Prime-Medicine.svg",
            "https://fprimecapital.com/wp-content/uploads/2017/04/Quovo.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/Recurly.svg",
            "https://fprimecapital.com/wp-content/uploads/2017/06/Riskrecon.svg",
            "https://fprimecapital.com/wp-content/uploads/2019/01/Sana-Biotechnology.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/Semma-Therapeautics.svg",
            "https://fprimecapital.com/wp-content/uploads/2019/11/Snapdocs.svg",
            "https://fprimecapital.com/wp-content/uploads/2016/07/Toast.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/Ultragenyx.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/US-Healthvest.svg",
            "https://fprimecapital.com/wp-content/uploads/2019/10/Vendr.svg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/Verve.svg",
            "https://fprimecapital.com/wp-content/uploads/2017/02/WelbeHealth.svg",
            "https://fprimecapital.com/wp-content/uploads/2017/08/Wellframe.svg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/stacie-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/08/John-Lin2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/20190530-f-prime-capital-1276-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2023/08/Square-Crop_Raj_2-150x150.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/10/Ishani-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0379-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/stacie-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/02/20200224-f-prime-capital-0050-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/stacie-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/10/SL-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/stacie-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0072-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0379-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0072-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0379-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2023/06/230516_clifford_fprime_headshots_DSF0590-square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/20190530-f-prime-capital-1276-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/08/John-Lin2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2023/06/230516_clifford_fprime_headshots_DSF0590-square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0072-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0072-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/20190530-f-prime-capital-1276-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/08/John-Lin2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2020/08/John-Lin2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/20190530-f-prime-capital-1276-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/02/20200224-f-prime-capital-0050-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2023/06/230516_clifford_fprime_headshots_DSF0590-square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/stacie-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0072-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/09/AA-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/20190530-f-prime-capital-1276-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2022/01/Portrait-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0379-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0329-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/08/20190813-f-prime-capital-0072-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/02/shervin-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2023/06/230516_clifford_fprime_headshots_DSF0590-square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2022/01/Portrait-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brian-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/01/2019_01_16_FPrime_29926_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/stacie-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/05/20190530-f-prime-capital-1276-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0379-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2022/01/Portrait-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/03/BM-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/alex-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2019/03/20190530-f-prime-capital-0747-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2023/06/230516_clifford_fprime_headshots_DSF0590-square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/10/8-roads.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0325-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/David-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/09/jessica-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/01/2019_01_16_FPrime_30087_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20181129-f-prime-capital-0446_square2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/ketan-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/gaurav-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/11/ben-gorman-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/jon-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2018/12/brett-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2016/02/sanjay-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2024/06/20240624-f-prime-capital-0306-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/20190530-f-prime-capital-0720-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2020/02/20200224-f-prime-capital-0050-1-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/nihal-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://live-f-prime-capital.pantheonsite.io/wp-content/uploads/2015/08/fidelity-ventures-logo.png",
            "https://fprimecapital.com/wp-content/uploads/2016/02/chong-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2021/06/AW-Square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/robert-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/03/2019_01_16_FPrime_30520_square-150x150.jpg",
            "https://fprimecapital.com/wp-content/uploads/2015/01/carl-2-150x150.jpg",
            "https://fprimecapital.com/wp-content/themes/f-prime-wp-theme/static/img/linkedin.svg",
            "https://fprimecapital.com/wp-content/themes/f-prime-wp-theme/static/img/twitter.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2019-01-10T17:50:32+00:00",
        "summary": "",
        "meta_description": "We create and invest in healthcare and technology companies that improve lives all over the world.",
        "meta_lang": "en",
        "meta_favicon": "https://fprimecapital.com/wp-content/themes/f-prime-wp-theme/static/img/favicons/favicon.ico",
        "meta_site_name": "F-Prime Capital",
        "canonical_link": "https://fprimecapital.com/portfolio",
        "text": "ABK Biomedical is organized to research, develop and commercialize breakthrough medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors. Specifically, ABK holds intellectual property in the focus area of inorganic polymer microspheres, targeted at the growing field of embolotherapy within the Interventional Radiology/Interventional Oncology medical disciplines. The company possesses advanced intellectual capital and its own R&D and manufacturing facilities for developing and commercializing unique, breakthrough embolotherapy products. Learn more at www.abkmedical.com.\n\nAdela (formerly DNAMx) is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. The company’s genome-wide methylation analysis technology has the unique ability to distinguish the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially target those informative regions for sequencing. Learn more at www.adelabio.com.\n\nAera Therapeutics is a biotechnology company leveraging its proprietary protein nanoparticle (PNP) delivery platform to unlock the full potential of genetic medicines. Aera’s platform, based on endogenous human proteins, is being developed to address the limitations of today’s delivery technologies and to expand the reach of genetic medicines to different tissues and applications, in order to benefit more patients across more disease areas. Aera’s licensed technology also includes a therapeutic enzyme platform based on the discovery of novel, compact and programmable gene editing enzymes. Aera is headquartered in Boston and has raised $193 million to date from leading life sciences investors. To learn more, please visit www.aeratx.com.\n\nAirespace was a market leader in the design and development of wireless networking platforms that support business-critical applications. The company’s AireWave Director(TM) Software provided dynamic RF intelligence for network optimization, air tight security, seamless mobility, and support for real-time applications, such as voice. With Airespace, enterprises could maximize the value of mobility by putting the air space to work. Airespace was acquired by Cisco in 2005.\n\nAlbert Invent empowers organizations to accelerate innovation with its state-of-the-art R&D platform. Built for chemistry and materials science, and powered by AI and Machine Learning, Albert’s collaborative, secure end-to-end platform delivers data insights and tools throughout the R&D process to accelerate speed to market. Albert is being utilized by some of the largest companies in the industry, along with emerging startups around the world. Learn more at https://www.albertinvent.com/\n\nAmber Therapeutics is developing Amber-UI, a breakthrough adaptive neuromodulation therapy to treat women suffering with mixed urinary incontinence with the hope of transforming the clinical outcome and quality of life of a large untreated population. Amber-UI runs on the Company’s fully implantable Picostim system that targets the pudendal nerve to both stimulate and sense physiological responses. The therapy is configurable to the individual’s need and can respond dynamically to different events, adapting as needed between modes of operation. Amber’s technology platform is highly versatile and can be used to explore other novel therapy applications in both the pelvis and the broader nervous system, demonstrated by the work being carried out by the Company’s academic partnerships. Learn more at www.amber-tx.com.\n\nAmplifyMD is a turnkey specialty access platform connecting the over 3,300 medical institutions with a lack of specialty access – often in rural or small regions of the United States – to a network of leading specialists. The company provides both the clinical team as well as the software to streamline and automate virtual care delivery and billing workflows and integrates seamlessly with hospitals’ existing EHRs. Learn more at www.amplifymd.com.\n\nAppliedVR is a leader in digital therapeutics, pioneering virtual reality-based treatments that address the complexity of chronic pain with a mission to empower patients with the tools to live life, beyond chronic pain. Rooted in cognitive behavioral therapy and mindfulness, AppliedVR’s EaseVRx is the first VR-based prescription therapeutic to receive Breakthrough Device Designation by the FDA. Learn more at www.appliedvr.io.\n\nArgyle provides a single global access point to employment data. From that access point, any business can process verifications, gain real-time transparency into earnings as well as view and update worker profile details. By removing the barriers between a worker, the companies they make money from, and the business they buy services and products from Argyle has reimagined how employment data can be used. Argyle was founded in 2018 and operates out of New York. Learn more at www.argyle.io.\n\nAudacy is a space communications service provider delivering continuous connectivity and data in real time to spacecraft operators. With a spectrum license granted by the U.S. Federal Communications Commission (FCC) in June 2018, and by deploying a network of medium Earth orbit relay satellites and ground facilities, Audacy will provide the first commercially available inter-satellite data relay network, enabling seamless low-Earth orbit coverage and always-on connectivity from ground to lunar orbit. To learn more, visit https://audacy.space.\n\nAvantStay delivers exceptional, unique stays for group travelers. The company has built a tech-enabled millennial hospitality brand to be the new standard for group experience. Unlike typical short-term rentals, Avantstay controls the entire guest experience. This allows the company to ensure the quality of a guest’s stay will be consistent across all homes and to deliver hotel-level comfort in an authentic differentiated setting. Learn more at avantstay.com.\n\nBetter Life Partners is a provider of high-quality, integrated medical and behavioral healthcare to people not well served by the traditional system. The company’s offerings include group therapy sessions with a special curriculum that utilizes evidence-based cognitive and dialectical behavioral therapy to build a sense of community and purpose toward a better life, enabling patients of substance abuse to be provided with aid and support to get sober. Learn more at www.betterlifepartners.com.\n\nBison Trails is a blockchain infrastructure platform that was acquired by Coinbase in January 2021. The platform provides a suite of services, including: “Query & Transact”, enabling developers to more easily retrieve and analyze data generated from blockchain networks for trading, research or development purposes, and “Participate,” enabling companies to participate in a blockchains proof of stake (PoS) consensus mechanism and earn newly issued cryptocurrency rewards. These services are integrated into Coinbase Developer Platform and are offered through the Coinbase website. Learn more at www.coinbase.com/developer-platform.\n\nBlispay makes financing easy and accessible for merchants and shoppers. The company provides point-of-sale financing with no integration and no additional costs to the merchant, ultimately helping businesses increase sales while providing consumers with better buying options everywhere they shop. Approved shoppers will additionally receive the Blispay credit card and continue to receive no interest, no payments on all purchases over $199 if paid in full in six months, plus automatic 2 percent cash back everywhere Visa is accepted. Located in Baltimore, Blispay’s team includes pioneers of the financing industry with experience that spans banking, credit and retail. Blispay was acquired by Alliance Data in 2019. Learn more at www.blispay.com.\n\nCadence Neuroscience is a medical device company developing new therapies for the treatment of epilepsy and other neurological disorders. The company’s core technology was developed at Mayo Clinic and is under clinical evaluation. Founded in 2017 and headquartered in Redmond, Washington, Cadence is led by seasoned executives with extensive backgrounds in neural implant product development and clinical studies. Learn more: https://www.cadenceneuro.com/\n\nCanary Technologies is modernizing the hotel tech stack, with the first mobile web end-to-end Guest Management System, digitizing everything from post-booking through checkout. Trusted by thousands of hotels in more than 65 countries, including Four Seasons, Choice Hotels, Standard Hotels and Ace Hotel Group, Canary’s solutions help hotels eliminate paper processes, boost revenue with upsells, raise staff efficiency, ensure PCI compliance, improve the guest experience, and reduce chargebacks and payment fraud. Learn more at canarytechnologies.com.\n\nCapital Rx is built around the mission of changing the way prescription drugs are priced and patients are serviced. A health technology company daring to reimagine the healthcare industry, Capital Rx is executing on that mission with its enterprise pharmacy platform JUDI™, which connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement and increasing efficiency to achieve the highest standards of clinical care. Learn more at www.cap-rx.com.\n\nCaplin Point Laboratories Limited is a fast growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. Caplin Point Laboratories Limited has state of the art manufacturing facilities that cater to a complete range of finished dosage forms. The Company has also entered regulated markets such as US through its Wholly Owned Subsidiary Caplin Steriles Limited. Learn more at www.caplinpoint.net.\n\nCarrot Fertility is a global fertility benefits provider for employers, built to support employees through their entire fertility healthcare journey. Companies use Carrot to customize a fertility benefit that provides employees financial, medical, and emotional support as they pursue parenthood, resulting in better clinical outcomes. Carrot’s program includes egg freezing, in vitro fertilization (IVF), adoption, donor and gestational carrier services; Carrot Rx, a premium pharmacy experience, at significant savings; Carrot Pregnancy; and the Carrot Card®, a flexible fertility benefits debit card employees can use to pay for their care. Learn more at www.get-carrot.com.\n\nCasa is the secure home for your Bitcoin. The Company builds tools at the forefront of Bitcoin self-custody, enabling individuals to take control of their wealth by holding their own Bitcoin private keys in an easy and secure manner. Casa is building for a future where self-custody is default and every individual, family, and business can freely manage their own wealth and data. Learn more at casa.io.\n\nCentivo is a new type of self-funded health plan built specifically for employers and their employees and families. The Company targets zero healthcare trend and improved healthcare outcomes by rewarding members and providers for smart choices and actions while delivering an exceptional member experience. Centivo serves as a health plan or third-party administrator (TPA) for employers and partners closely with local health plans and TPAs to enhance their offerings. Learn more at www.centivo.com.\n\nCHARM Therapeutics is a 3D deep-learning research Company discovering and developing transformational medicines. Based on the award-winning discoveries of David Baker in protein-folding, CHARM has developed a proprietary technology based on the first rapid, accurate protein/ligand co-folding algorithm. The Company’s mission is to use these insights to address challenging targets in cancer and other disease areas and discover and develop new drugs against these targets. Learn more at www.charmtx.com.\n\nCoin Metrics is the leading provider of crypto financial intelligence, offering network data, market data, indexes and network risk solutions to the most prestigious institutions touching cryptoassets. Coin Metrics was founded in 2017 as an open-source project to determine the economic significance of public blockchains. Today, they expand on that original purpose to empower people and institutions to make informed crypto financial decisions. Coin Metrics aim to usher the world’s premier financial institutions into crypto with the most trusted data and insights. Learn more at www.coinmetrics.io.\n\nConnexPay is revolutionizing the payment distribution process by offering a combined merchant acquiring and virtual card issuing solution for mid-sized companies. The company’s technology simplifies an antiquated workflow, eliminates the need for pre-funded accounts, reduces supplier risk and the cost of accepting card payments while safeguarding consumer spend. Backed by F-Prime Capital and BIP Capital, ConnexPay is becoming the industry leader in payments for industries historically viewed as high risk to payment providers. Learn more at www.connexpay.com.\n\nCurie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services – everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly. Learn more at Curie.Bio.\n\nDUST Identity is a leading authentication and anchored digital thread solution for real-world objects that connects data to physical things. DUST Identity’s award-winning anchored digital thread solution delivers the ability to track and trace an object’s pedigree and provenance throughout its lifecycle – providing access to the right information at the right place and time. Learn more at www.dustidentity.com.\n\nElementus helps solve the toughest blockchain data problems so organizations can navigate web3 safely and with confidence. Its intelligence platform is used by financial institutions to build the future of finance and commerce on the bedrock of blockchain, and by key U.S. governmental agencies to solve some of the most high-profile ransomware investigations. Elementus helps organizations investigate on-chain activities, identify risk, discover valuable market intelligence or a combination of all three. By providing a complete view into flows of funds at the most granular level, Elementus delivers actionable insights and transparency needed to grow and prosper safely in a web3 world. Learn more at elementus.io.\n\nEleos is pioneering CareOps Automation. By consolidating the entire behavioral care workflow — everything from progress notes all the way to session intelligence— clinicians are freed from time-consuming operational burdens. Eleos takes care of CareOps, honing in on automating operational necessities, including all documentation, compliance administration as well as providing deep clinical insights through session intelligence. Eleos makes evidence-based behavioral care a reality so clinicians, providers, and networks can measurably and comparatively track treatment and progress. Learn more at eleos.health.\n\nElucidata was founded in 2015 by University of Chicago and MIT graduate Dr. Abhishek Jha and IIT Delhi alumnus Swetabh Pathak. The company’s cutting-edge platform Polly operates on unique Bio-NLP technology that cleans and links 26+ R&D data types and caters to companies in various stages of their drug discovery process. The platform helps data science teams scale by providing them 70 TB of ML-Ready biomedical data, from ~30 public and proprietary sources. Today, 3 of the top 10 pharmaceutical companies are using Polly to fast track their R&D initiatives. Learn more at www.elucidata.io.\n\nEmbark Veterinary, Inc. launched in 2015 with a mission to end preventable disease in dogs. An Embark Dog DNA Test enables pet owners to learn about their dog’s breed, ancestry, health, and what diseases may be in the future – all with a simple cheek swab. By using 100 times more genetic information than any other test available, the company offers the most accurate results on the market. Embark was started by two brothers, Adam and Ryan Boyko, who have a passion for scientific research and a lifelong love of dogs. Embark is an official research partner with Cornell University College of Veterinary Medicine. Learn more at www.embarkvet.com.\n\nEnsoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g. chemotherapy). Learn more at www.ensoma.com.\n\nEnzene is an innovation-driven biotech company a subsidiary of Alkem Laboratories Ltd. (one of the top five pharmaceutical companies in India*) located in Pune, India. Enzene’s focus lies in producing biosimilars, novel biologics, synthetic peptides and phytopharmaceuticals. Enzene also offers a range of biologics CDMO and CMO services with capabilities from clone development up to GMP manufacturing supported by bio-reactor capacities ranging from 20 litres to 2000 litres.\n\nEthena is a digital finance company focused on providing innovative solutions within the cryptocurrency and blockchain sectors. The company offers services such as developing and managing stablecoins, which are cryptocurrencies pegged to traditional assets like the US dollar to minimize price volatility. Additionally, Ethena operates in the decentralized finance (DeFi) space, enabling users to participate in financial activities like lending, borrowing, and trading without traditional intermediaries through the use of smart contracts on blockchain networks. Ethena also provides tools for managing digital assets, helping users securely store, transfer, and utilize their cryptocurrencies with services like wallets and investment products. The company is committed to leveraging blockchain technology for its transparency, security, and efficiency, aiming to bridge the gap between traditional finance and the digital economy. Through these efforts, Ethena makes it easier for individuals and businesses to adopt and benefit from cryptocurrency technologies. Learn more at ethena.fi.\n\nThrough the synergies of cross-disciplinary collaboration and technological innovation, EurekaBio has consistently pushed the boundaries of therapy. EurekaBio has brought forth advanced cellular drug production solutions and the EuLV™ lentiviral vector platform. These breakthroughs, including high-titer stable lentiviral vector packaging and producer cell lines, are poised to play a pivotal role in the global commercialization of CGT drugs. Our ultimate aim is to bring tangible benefits to patients worldwide by ushering in a new era of advanced and accessible therapies. Learn more: https://www.eurekabio.com/\n\nEven Financial is an NYC based FinTech company focused on evolving how financial institutions connect with consumers and provide them with the best product recommendations at the right moment, facilitating an on-demand and personalized customer acquisition experience across the entire financial services ecosystem. The Even platform serves as a trusted intermediary for financial institutions – including Prosper, Lending Club and Marcus by Goldman Sachs – that helps find consumers and distribute their products digitally. Even’s industry-leading search, comparison and recommendation API is an infrastructure layer that enables hundreds of diverse partners – including Credit.com, Transunion, Money Under 30, Credit Sesame and The Penny Hoarder – to power comprehensive personal finance websites, mobile apps and other offerings with a modern platform that is proven to accelerate customer acquisition through optimal product recommendations, lowering cost of acquisition and maximizing monetization. Even Financial was acquired by MoneyLion in 2021.\n\nFigment’s purpose is to build a better Internet by increasing usage of the next generation of Proof of Stake blockchains. These efficient blockchains give people greater control of their data, more privacy, and increase financial inclusion. By eliminating intermediaries they also limit the power of centralized data monopolies, rent seeking institutions and anti-social algorithms. Learn more at www.figment.io.\n\nFlywire (NASDAQ:FLYW) solves complex payment problems for businesses and institutions to empower new opportunities globally and locally. Its full-service billing, payment and receivables solutions connect all the entities involved to make those transactions faster, more secure, less expensive, and more transparent. Clients in a variety of industry verticals use Flywire’s platform to tailor the payment experience for their customers and to create a single point of visibility and control for payer engagement and receivables management – from invoicing and payment through reconciliation. Learn more at www.flywire.com.\n\nFunnel’s product is a Data Core used by 800 forward-thinking organizations across a wide set of industry verticals to automatically import marketing data and make it Business-Ready. The Swedish Software-as-a-Service (SaaS) company was founded by Fredrik Skantze and Per Made in 2014. Funnel has 140 employees and offices in Stockholm and Boston. Learn more at funnel.io.\n\nGrove provides node infrastructure services for applications, enterprises, and users to interact with blockchains. At its core, Grove is a RPC (Remote Procedure Call) service that enables users to read and write data to over 40 blockchains. Grove is built on top of the Pocket Network, a global, decentralized network of nodes. Through their portal, Grove provides a performance layer that enhances the reliability and scalability of Pocket while also ensuring the high quality service users demand. Learn more at grove.city.\n\nGuros is a digital insurance marketplace in Mexico that’s transforming the entire insurance experience, from purchasing to managing vehicle insurance. We’re on a mission to democratize insurance in Latin America; both for end-customers and neobanks/fintechs who want to embed insurance into their platform, but need to do so in a much simpler, faster, and reliable way. Learn more at www.guros.com.\n\nHone is a Live Learning Platform for organizations to teach transformational leadership, management, and people skills at scale. The company empowers HR and Learning & Development teams to tackle people development in a modern way, with easy deployment of small-group, live cohort learning at scale, and data and tools to measure its impact. Through a blend of live online cohort-based programs, world-class instructors, and a powerful behavior change platform, Hone cultivates soft skills with hard data, leading to lasting behavior change in 90% of learners who go through our programs. Hone has trained thousands of learners in 58+ countries, and serves a rapidly expanding list of clients including GoFundMe, ServiceNow, Rover, Grove Collaborative and more. For more information, visit www.honehq.com.\n\nHoseki builds financial plumbing for the bitcoin-native economy that allows investors to verify and use their holdings in ways that were previously inaccessible. By empowering bitcoin holders with a standardized proof-of-assets service, Hoseki will unleash the bitcoin economy to be larger and more active than ever. Learn more at hoseki.app.\n\nIglu is a Brazil-based mobile point-of-sale (PoS) software with native omnichannel capabilities for retailers with omnipresence. It offers retailers an Apple-Store-like delightful product by (1) replacing bulky in-store equipment with a mobile PoS, (2) stitching together disconnected tools such as payments, e-commerce platforms, ERP etc., and (3) integrating with all major credit, debit cards, alternative payment methods such as installment, and the rising real-time payment system in Brazil — PIX. Learn more at https://www.iglu.com.br/\n\nInvetx is a pioneer in creating novel, protein-based animal health therapeutics to transform standards of care in veterinary medicine. The company leverages a best-in-class, fully integrated biotechnology platform for the discovery, development, and manufacturing of veterinary monoclonal antibodies, and is developing a diverse product pipeline addressing chronic and severe diseases in the veterinary species. In July 2024, Invetx was acquired by Dechra Pharmaceuticals Limited (Dechra), a global specialist veterinary pharmaceuticals business. Learn more at www.invetx.com.\n\nKiln is the leading enterprise-grade staking platform, enabling institutional customers to stake assets, and to whitelabel staking functionality into their offering. Kiln runs validators on all major PoS blockchains, with over $4b of crypto assets being programmatically staked and over 4% of the Ethereum network, running on a multi-cloud, multi-region infrastructure. Kiln also provides a validator-agnostic suite of products for fully automated deployment of validators, reporting and commission management, enabling custodians, wallets and exchanges to streamline staking operations across providers. Kiln is SOC2 Type 2 certified. Learn more at www.kiln.fi.\n\nLatchel is an award winning property management technology company that empowers property managers to provide unbeatable customer experience with streamlined maintenance operations, and top-tier resident amenities. With built in layers that elevate the resident experience, property managers are also able to increase their revenue by implementing the service as a resident paid amenity. Renters get better service levels that average a 4.8/5 star rating, and property managers can increase both operational efficiency and overall profitability. Learn more at www.latchel.com\n\nLighthouse (formerly OTA Insight) is the leading commercial platform for the travel & hospitality industry. We transform complexity into confidence by providing actionable market insights, business intelligence, and pricing tools that maximize revenue growth. We continually innovate to deliver the best platform for hospitality professionals to price more effectively, measure performance more efficiently, and understand the market in new ways. Trusted by over 65,000 hotels in 185 countries, Lighthouse is the only solution that provides real-time hotel and short-term rental data in a single platform. We strive to deliver the best possible experience with unmatched customer service. We consider our clients as true partners—their success is our success. Learn more at mylighthouse.com.\n\nLogixboard is the digital partner for freight forwarders to succeed in today’s highly competitive market. Our web-based platform empowers freight forwarders to do their work more efficiently, increasing customer satisfaction, and unlock the power of their data. Logixboard is a recent graduate of Techstars and is based in Seattle with offices in Bogota, Colombia. For more information, visit www.logixboard.com.\n\nManthan is a leading cloud analytics company for consumer facing businesses. Their analytics solutions are powered by AI, cloud and prescriptive capabilities. They are unique in their ability to use machine intelligence to process every decision context and respond automatically with actions and recommendations to manage every aspect of a consumer business, whether its marketing, merchandising, channel/store, demand or supply. Learn more at www.manthan.com.\n\nMathison is the world’s first DEI Operating System. Its end-to-end platform transforms organizations’ hiring and retention strategies to increase diversity with a single place to build their DEI action plan, measure growth and mobilize every team with education and tools. A leader in DEI innovation and research, their book, Hiring for Diversity, was named a bestseller and is referenced by organizations across the globe. Mathison works with a wide range of employers of all sizes including companies like Sonos, TripAdvisor, 23andMe, HelloFresh, Bowery Farms, Bristol Myers Squibb and non-profits from Sundance Film to The World Economic Forum. Learn more at www.mathison.io.\n\nMetsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. For more information, please visit us at www.metsera.com.\n\nmindSHIFT is one of the largest IT outsourcing and cloud services providers. The company has supported our clients with tailored and trusted technology solutions for more than 15 years. From day-to-day IT to major systems modernization, count on mindSHIFT’s technology expertise and personalized customer care for all of your IT needs. mindSHIFT was acquired by Roche Company in 2014. Learn more at www.mindshift.com.\n\nMozper is bringing the weekly allowance into the digital era in Latin America. About 70% of the population in the region has never received formal financial education, and do not have the right tools to teach their children. In Brazil and Mexico alone, parents give more than $10B each year in pocket money to kids. Mozper offers a Visa debit card and an app where parents can give their kids an allowance, set spending rules (so they can’t blow it all on video games), assign chores and even create and track savings goals. Mozper is currently available in Mexico. Learn more at www.mozper.com.\n\nAcknowledged by Forbes as one of the “Disruptive Technology Companies To Watch in 2019”, Mythical Games is enabling a gaming ecosystem that brings players, creators, brands and game developers together through personalized experiences and content. Led by gaming industry veterans, the team specializes in building games around player-owned economies and has helped develop major franchises including Call of Duty, World of Warcraft, Guitar Hero, Marvel Strike Force, Skylanders, and Minecraft: Story Mode. Learn more at mythical.games.\n\nIn 1999, Napster changed the music industry forever when it launched the world’s first peer-to-peer music sharing service. Peaking at 85M users, for many, Napster was not only their first experience of digital music but also their first real social media experience. Napster is now once again gearing to revolutionize the music industry, evolving music streaming from being an access-based monthly subscription model to a social music platform and marketplace that connects artists and fans, unlocking unprecedented new creative and commercial opportunities. Learn more at www.napster.com.\n\nNebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. Nebula Genomics was acquired by ProPhase Labs in 2021.\n\nNeo4j is the leading graph database platform that drives innovation and competitive advantage at Airbus, Comcast, eBay, NASA, UBS, Walmart and more. Thousands of community deployments and more than 300 customers harness connected data with Neo4j to reveal how people, processes, locations and systems are interrelated. Using this relationships-first approach, applications built using Neo4j tackle connected data challenges including artificial intelligence, fraud detection, real-time recommendations and master data. Find out more at neo4j.com.\n\nNeumora Therapeutics, Inc. (NASDAQ: NMRA) is a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Neumora is redefining neuroscience research and development with a data-driven precision neuroscience platform to cut through brain disease heterogeneity to match the right patient populations to targeted therapeutics. The Company’s precision data science platform integrates multiple data types to define patient subtypes through the development of Data Biopsy Signatures™ and Precision Phenotypes™. Learn more at www.neumoratx.com.\n\nNOCD is the #1 telehealth provider for the treatment of obsessive-compulsive disorder (OCD) and the leading Community-Driven Therapy company. The company helps people reclaim their lives with clinically proven OCD treatment by removing barriers to care, and by reducing the stigma associated with OCD. Inside the NOCD platform, members can quickly access a national network of licensed therapists that specialize in Exposure and Response Prevention (ERP), the “gold standard” for OCD treatment. Learn more at www.treatmyocd.com.\n\nNvelop Therapeutics was founded in 2022 to address the challenge of efficiently delivering therapeutic cargoes to target cells in vivo. Nvelop’s next-generation platforms enable highly efficient and cell-specific in vivo delivery of a wide range of cargoes to many types of target cells. The two platforms were independently developed in the labs of scientific co-founders and gene editing pioneers Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung at Massachusetts General Hospital. With its own pipeline of therapeutics and through strategic collaborations, Nvelop aims to use these programmable, non-viral platforms to transform delivery for a broad range of genetic medicines and modalities in order to treat many previously undruggable diseases. For more information, visit www.nveloptx.com.\n\nOdaseva partners with the largest and most sophisticated organizations in the world to accelerate their trust in business-critical cloud applications. Fortune Global 500 industry leaders use Odaseva technology to back up and restore data, ensure data privacy and regulatory compliance, and use data to drive operational agility. Engineered for Salesforce by Salesforce experts and endorsed by Salesforce Ventures, Odaseva is trusted by 30+ million users and has received 100% five-star reviews over eight years on the Salesforce AppExchange. Learn more at www.odaseva.com.\n\nOnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients. Learn more: https://www.oncusptx.com/\n\nFounded in 2018, OpenNode is the world’s leading bitcoin payment processor and infrastructure provider, connecting the world with revolutionary payment technology. OpenNode provides secure, reliable bitcoin payment acceptance and payout solutions for businesses, platforms, and people everywhere. From payment buttons to hosted checkout, and e-commerce plug-ins to optimized APIs, OpenNode offers the benefits of instant, lowest cost payments made possible by Bitcoin, the world’s best decentralized payment network; and the Lightning Network, Bitcoin’s leading scaling solution. Learn more at www.opennode.com.\n\nThe unique makeup of the Optimus Ride team includes over 30 years of shared experience on the cutting edge of interdisciplinary research in self-driving technologies, electric vehicles, mobility-on-demand and other transportation systems. The team also has a decade of industrial and entrepreneurial experience spanning manufacturing robots, medical robots, shared vehicle fleet management and urban design. Building on this significant knowledge, the company will continue to leverage the latest advances in complex sensor fusion, mapping, computer vision and machine learning to ultimately deploy a new form of transportation system that enables safe, sustainable and equitable mobility access. This company was acquired by Magna in 2022.\n\nOwkin combines life-science and machine learning expertise to make drug development and clinical trial design more targeted and more cost effective. Owkin’s machine learning algorithms create models that predict disease evolution and treatment outcomes. These predictive models are implemented in clinical trials for enhanced analysis, surrogate endpoints, patient stratification, patient selection, and high-value subgroup identification. The impact of this research is faster discovery of better treatments at a lower cost. Learn more at www.owkin.com.\n\nParadigm is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Paradigm aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster. Learn more: www.paradigm.inc.\n\nParrot is a Mexican food tech startup that helps the country’s restaurants to digitize and optimize their operations through technology. Its ParrotConnect solution is an all-in-one platform for today’s restaurants: multi-brand and multi-channel, which allows the user to manage all business tasks from one device. Integrate orders from delivery apps, table service and take-away orders on the same screen, configuration of personnel permissions, menu editor, kitchen areas, types of payment, cashier operations, and real-time reports from a single management portal. Learn more at pos.parrotsoftware.io.\n\nPeptone is an innovative drug discovery company applying advanced biophysics, atomic-level experimental approaches, cutting-edge supercomputing and machine learning to the challenge of biopharmaceutical research and development. By bringing these proprietary approaches together, we are exploring the world of intrinsically disordered proteins (IDPs) – proteins without a fixed structure that play a significant role in health and disease – opening up the possibility of novel therapeutics against an entire class of high value and previously undruggable targets. Learn more at peptone.io.\n\nPrime Medicine (NASDAQ: PRME) is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly “search and replace” to restore normal genetic function and address the fundamental causes of disease. Prime Medicine envisions a world where Prime Editing can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients and shaping the future of gene editing. Learn more at www.primemedicine.com.\n\nProsper’s mission is to advance financial well-being. The company’s online lending platform connects people who want to borrow money with individuals and institutions that want to invest in consumer credit. Borrowers get access to affordable fixed-rate, fixed-term personal loans. Investors have the opportunity to earn solid returns via a data-driven underwriting model. To date, over $13 billion in personal loans have been originated through the Prosper platform for debt consolidation and large purchases such as home improvement projects, medical expenses and special occasions. Learn more atwww.prosper.com\n\nPuffer is defining a new industry standard for secure validator operations with the primary objective of preserving decentralization, with Anti-Slashing technologies designed to minimize the chance of slashing events. The company’s Secure-Aggregator technology provides the foundation to build a secure, scalable, and performant liquid staking protocol. Allowing permissionless and capital-efficient Node Operator (NoOp) participation allows anyone to join the PufferPool to help preserve Ethereum’s decentralization. Learn more at www.puffer.fi.\n\nQuantum Circuits, Inc. (QCI) was founded in 2015 with the goal of developing, manufacturing and selling the first practical and useful quantum computers based on superconducting devices. QCI was founded by pioneers in quantum devices and information processing from the Department of Applied Physics at Yale University. Their group has produced many scientific firsts, including the development of a “quantum bus” for entangling qubits with wires and the first implementation of a quantum algorithms and error-correction with a solid-state device. Learn more: www.quantumcircuits.com\n\nQuovo is a data platform providing connectivity to consumer financial accounts. Quovo centralizes, organizes, and enriches data from millions of accounts across more than 14,000 institutions to provide businesses with a comprehensive picture of each customers’ financial identity. With industry-specific solutions, clients from emerging fintech startups to Fortune 500 companies rely on Quovo for its seamless technology and rich data insights to deliver more personalized and frictionless customer experiences. Quovo’s unparalleled coverage of the financial ecosystem, powerful data analytics, and flexible deployment options propel businesses in uncovering opportunities to grow their relationships with customers. Quovo was acquired by Plaid in 2019. Learn more at www.quovo.com.\n\nRareStone (formerly Citrine Medicine) is a rare disease-focused therapeutics company focused on the Greater China market that was co-founded by Eight Roads Ventures, F-Prime Capital and Vivo Capital. RareStone is dedicated to improving the lives of rare disease patients by making diagnosis and essential treatments available and accessible for those who need them. Learn more at www.rarestonegroup.com.\n\nRDC (Receipts Depositary Corporation) is the first depositary that aims to make it as easy for QIBs to own digital and alternative assets as traditional securities. Using the DR construct that has been trusted by investors for nearly a century, the RDC platform provides asset protection, transparency, risk minimization and operational ease. RDC is not a bank and is not registered as a broker, dealer or investment adviser in any jurisdiction. Learn more at receiptsdepo.io.\n\nRecurly, Inc. delivered enterprise-grade subscription management to thousands of SaaS, media, mobile, consumer goods, productivity, and publishing businesses worldwide. Businesses like Sling TV, Asana, Unbounce, and BarkBox were dependent on Recurly’s ability to cut through the complexity of subscription management to drive recurring revenue growth. Since its launch in 2010, Recurly had deployed subscription billing for thousands of companies across 32 countries, making it the most trusted subscription management platform. Recurly was acquired by Accel-KKR in 2020.\n\nRialtic is an enterprise software platform empowering health insurers and healthcare providers to run their most critical business functions. Rialtic’s best-in-class payment accuracy product brings programs in-house and helps health insurance companies gain total control over processes that have been managed by disparate and misaligned vendors. Currently working with leading healthcare insurers and providers, the company is tackling a $1 trillion problem to reduce costs, increase efficiency and improve quality of care. Learn more at www.rialtic.io.\n\nRIGImmune is a platform biopharmaceutical company developing a novel investigational class of RNA immunotherapies termed “SLRs” for the potential pan-viral treatment and prophylaxis of viral respiratory diseases and selected cancers. The RIGImmune development candidates act to specifically modulate RIG-I, a host surveillance pathway that triggers the innate immune system to enhance an intrinsic response to RNA viruses, including influenza, RSV, rhinovirus, and SARS-CoV-2, and tumor DNA. The lead development candidate at RIGImmune is RIG-101.\n\nThe company was co-founded by the prominent Yale University professors, Anna Marie Pyle, Ph.D. and Akiko Iwasaki, Ph.D., who currently serve as scientific advisors to the company. Dr. Pyle co-discovered the RIG-I receptor family and conducted many of the first structural and biochemical investigations on the cytosolic protein, RIG-I. Dr. Pyle is also a specialist in RNA structure and design. She designed the stem-loop RNA therapeutics (SLR) for selective targeting of RIG-I using crystal structure data of RIG-I complexed with RNA and developed them as antitumor and anticancer compounds in collaboration with Dr. Iwasaki, whose expertise in mucosal immunity has been highly sought during the COVID-19 pandemic.\n\nRIGImmune is a UConn Technology Incubation Program (TIP) company located in Farmington, CT, was founded by Yale scientists, and has an experienced management team of successful biotech entrepreneurs and world-renowned scientists. Learn more at rigimmune.com.\n\nRippl is a new kind of mental health company focused on seniors and obsessed with its clinicians. Seniors with mental health challenges, especially neurocognitive conditions like Alzheimer’s disease and other dementias, are overlooked and under cared for, often without access to high quality, real-time, practical care. Leveraging a value-based approach, disruptive technology, and a relentless focus on empowering and enabling its clinicians, Rippl is pioneering a new care model to dramatically expand access to high quality, wraparound mental health care for seniors, their families, and caregivers. Rippl provides 24/7 support and personalized care when and where they need it – on the phone, online or in their living rooms. Learn more at www.ripplcare.com.\n\nRiskLens is the leading provider of quantitative cyber risk management software. Its platform is recognized as a mission-critical business application for cybersecurity and risk teams across the Fortune 1,000. RiskLens empowers large enterprises and government organizations to manage cyber risk from the business perspective by quantifying that risk in monetary terms. Clients depend on RiskLens solutions to better understand and communicate their cyber risk exposure in financial terms, prioritize their risk mitigations, measure the ROI of their security investments, and meet regulatory demands calling for the quantification of cyber risk. RiskLens is the only cyber risk quantification software purpose-built on FAIR, the standard quantification model for information security and operational risk. Learn more at www.risklens.com.\n\nSecuronix is working to radically transform all areas of data security with actionable security intelligence. Their purpose-built, advanced security analytics technology mines, enriches, analyzes, scores and visualizes customer data into actionable intelligence on the highest risk threats from within and outside their environment. Using signature-less anomaly detection techniques that track users, account and system behavior, Securonix is able to detect the most advanced insider threats, data security and fraud attacks automatically and accurately. Learn more at www.securonix.com.\n\nSeis is banking for the 44 million native Spanish speakers living in the US. Their mission is to build the most delightful, full-service banking experience for anyone who wants to bank in their native Spanish. Their goal is to make such an amazing banking experience that people will wish they spoke Spanish so they could bank with Seis. They’ll treat Spanish speakers as first-class citizens & end “dial 2 for Español”. Learn more at seis.com.\n\nSeyond (formerly Innovusion) is a leading developer of image-grade LiDAR sensor systems for level 4+ of the autonomous vehicle market. Its unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes its products an ideal choice for the most demanding applications. Learn more at seyond.com.\n\nShift Bioscience (Shift) is a Cambridge, UK-based biotechnology company focused on safe cellular reprogramming for rejuvenation. The company leverages a proprietary cellular age clock and an active machine learning approach to discover novel factors for safer cellular rejuvenation without the use of pluripotency-inducing reprogramming genes. Shift aims to enable the development of reprogramming-based therapeutics to prevent and treat age-associated diseases. Learn more at www.shiftbioscience.com.\n\nShinobi Therapeutics is a biotechnology company developing a new class of off-the-shelf immune evasive iPSC-derived cell therapies. Based on the research of scientific co-founders Shin Kaneko, M.D., Ph.D., at Kyoto University and Tobias Deuse, M.D., at University of California, San Francisco, Shinobi has created a new allogeneic CD8αβ iPS-T cell platform that demonstrates comprehensive immune evasion from all arms of the immune system. For more information, please visit www.shinobitx.com.\n\nSilq is on a mission to bring radical visibility and real-time data from the factory floor to brands around the world. We power sourcing, manufacturing and shipping for apparel, footwear, home goods and accessory brands. Our on-site experts provide real-time updates into the production process directly from the factory floor. Paired with Silq’s proprietary technology platform, brands are able to accelerate speed-to-market and improve product quality. Our customers include direct-to-consumer (DTC) and wholesale fashion and apparel brands such as Barry’s, Mightly, Mizzen+Main and Lambert in addition to design and production houses such as Pinpoint Merchandising and Stars Design Group. Learn more at www.onesilq.com.\n\nSimon Data is the first and only enterprise customer data platform with a fully-integrated marketing cloud. Moving beyond the limitations of both categories, Simon’s platform empowers businesses to leverage enterprise-scale big data and machine learning to power customer communications in any channel. Simon’s unique approach allows brands to develop incredible personalization capabilities without needing to build and maintain massive bespoke data infrastructure. Learn more at www.simondata.com.\n\nSkyline Therapeutics (formerly Geneception) is a fully-integrated gene and cell therapy based in Hangzhou and Shanghai, China. Founded by F-Prime Capital, Eight Roads Ventures China and Lilly Asia Ventures in 2018, Skyline’s mission is to become a preeminent gene and cell therapy company, working to deliver world-class therapeutics for patients in China and globally.\n\nFounded in 2013, Snapdocs is the industry’s leading digital closing platform. With its patented AI technology, Snapdocs is on a mission to perfect mortgage closings and transform a $2 trillion pillar of the U.S. economy. Powering over 750,000 closings a year, Snapdocs is leading the charge to modernize, streamline, and improve the mortgage process for lenders, borrowers, and settlement. Snapdocs is the only solution with a proven track record of creating a single, scalable process for every closing, whether wet, hybrid, or digital. Every day, over 50,000 mortgage professionals rely on Snapdocs’ technology to automate manual work and digitize paper processes that plague the industry. Snapdocs is a rapidly growing San Francisco based real estate technology company backed by prestigious Silicon Valley blue-chip venture capital funds, like Y Combinator, SV Angel, Sequoia Capital, and F-Prime Capital. Learn more at www.snapdocs.com.\n\nSnapsheet is the leading provider of virtual claims solutions, using powerful technology to improve workflows for more than 60 insurance carriers around the world. Snapsheet creates a simple claims process, starting with virtual estimations all the way to final repairs and payment, by streamlining communication between consumers, shops and carriers. Snapsheet takes complicated processes and makes them fast and simple for everyone involved. Learn more at www.snapsheetapp.com.\n\nSolidus Labs is the category-definer for crypto-native triple T (T3) market integrity solutions – trade surveillance, transaction monitoring, and threat intelligence. Their mission is to enable safer crypto trading throughout the investment journey across all centralized and DeFi markets. As the founder of industry leading initiatives like the Crypto Market Integrity Coalition and DACOM Summit, and in everything they do, Solidus is deeply committed to ushering in the financial markets of tomorrow. Learn more at www.soliduslabs.com.\n\nSpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize. Learn more at www.spectrumai.com.\n\nSpry is a purpose built platform for the physical rehabilitation industry. It helps therapists streamline care delivery, increase patient inflow and reduce administrative costs while also helping patients improve outcomes by making it easy to understand and follow care plans. Spry has been able to achieve this by using physical rehabilitation specific workflows, advanced computer vision technology and new age product design paradigms. Learn more: www.sprypt.com.\n\nStage is on a mission to empower builders and innovators to create enduring technology. Stage is a dynamic monetization platform for early- and growth-stage software companies. Starting with flexible plans and paywalls, the platform gives product teams the ability to understand, measure, and capture value from customers with confidence. Stage was co-founded by CEO Patrick Despres-Gallagher and CTO Kaiser Leib in October 2021 with remote operations and hubs in California and Montana. Patrick was previously one of the early Product Managers at Loom and RapidSOS as well as a family office investor focused on enterprise software. Kaiser was previously an early Software Engineer at Juniper Square and SoFi. Learn more at www.heystage.com and follow them on Twitter and LinkedIn.\n\nT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases. Learn more: https://t-therapeutics.com/\n\nTeleo is revolutionizing heavy equipment operations by turning construction and mining equipment into semi-autonomous robots. Their Teleo Supervised Autonomy technology lets contractors operate existing heavy equipment without an operator in the cab, letting a single operator control multiple pieces of equipment from a remote desk. This increases productivity, safety, and operator satisfaction — critical challenges in the construction and mining industries. Teleo is backed by UP.Partners, F-Prime Capital, K9 Ventures, YCombinator and a host of industry luminaries. Learn more at teleo.ai.\n\nTenpoint Therapeutics is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company is addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanently restore vision. Learn more: www.tenpointtx.com.\n\nTetraphase (NASDAQ: TTPH) is a biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections; its lead product XERAVATM (eravacycline) is approved for the treatment of complicated intra-abdominal infections by the FDA and EMA. Learn more at www.tphase.com.\n\nThe Giving Block, a Shift4 company, is the platform helping nonprofits fundraise more effectively from modern philanthropists. Pioneers of the “Crypto Philanthropy” movement, The Giving Block developed the leading solutions for cryptocurrency donations, taking crypto and NFT donations mainstream in the nonprofit sector. The Giving Block’s team then developed a stock giving experience built to empower even more donors to give non-cash assets. When combined, The Giving Block’s product suite empowers more donors than ever to give assets to their favorite causes. Today, thousands of nonprofits are using The Giving Block to fundraise from modern philanthropists. Learn more at www.thegivingblock.com.\n\nThreat Stack enables growth-driven companies to scale securely and meet complex cloud security needs by identifying and verifying insider threats, external attacks, and data loss in real time. With a comprehensive approach to intrusion detection, Threat Stack empowers security and operations to better manage risk and compliance across their entire infrastructure, including cloud, hybrid cloud, multi-cloud, and containerized environments. Threat Stack was acquired by F5 Networks in 2021.\n\nLaunched in 2013, Toast powers successful restaurants of all sizes with a technology platform that combines restaurant POS, front of house, back of house and guest-facing technology with a diverse marketplace of third-party applications. By pairing technology with an unrivaled commitment to customer success, Toast helps restaurants streamline operations, increase revenue and deliver amazing guest experiences. Toast was named to the 2018 Forbes Cloud 100 and recognized as the third fastest-growing technology company in North America on the 2017 Deloitte Fast 500. Toast went public in 2021 (NYSE:TOST). Learn more at www.toasttab.com.\n\nTokensoft was founded in 2017 on three pillars: compliance, scalability and cybersecurity. They’re proud to continue to uphold these values today as we bring the future of web3 to mainnet. To date, Tokensoft has partnered with projects such as Avalanche, Arbitrum and the Graph to help build their communities, the right way. Learn more at www.tokensoft.io.\n\nToku is a Chile-based payment orchestration company that offers a solution for collecting recurring payments in LatAm. It has three main value propositions: 1) increase payment acceptance rate via dynamic routing; 2) incur the lowest possible cost by using account-to-account payment; 3) have the best-automated payment experience. Learn more at trytoku.com.\n\nUnison is the leading provider of home ownership investments, modernizing home financing through long-term partnerships. Unison works with lenders, regulators and institutional investors to integrate home ownership investing into the U.S. housing finance system. Unison HomeBuyer helps purchasers buy the home they want with less debt and risk, typically by doubling the down payment. The larger down payment makes it easier to qualify for a loan, increases buying power, lowers the monthly payment and/or allows a buyer to reserve cash. Unison HomeOwner provides current homeowners with cash to eliminate debt, remodel, pay for school, invest or use as a cash cushion, without the added debt or payments of a home equity loan or HELOC. Learn more at www.unison.com.\n\nValor Performance is the premier digital learning platform focused on sustaining performance for executives and sales leaders. Valor’s software platform delivers personalized and research-based exercises as well as dedicated Valor coaches, who integrate the latest research on stress management and burnout with the insights of world-class athletes. Learn more at www.valorperform.com.\n\nFounded in 2018, VALR is a global cryptocurrency exchange serving over 1,000 corporate and institutional clients and close to 700,000 users worldwide. Headquartered in Johannesburg, VALR is licensed by the Financial Sector Conduct Authority (FSCA) in South Africa, approved to offer services in Europe, and has received initial approval from Dubai’s VARA. Learn more at valr.com.\n\nVerve Therapeutics (NASDAQ: VERV) is a biotechnology company created with a singular focus: to protect the world from heart disease. Verve is developing therapies to safely edit the genome of adults and confer lifelong protection from coronary artery disease, the most common form of heart disease and the leading cause of death worldwide. Learn more at www.vervetx.com.\n\nVestwell is a digital platform that makes it easier to offer and administer 401(k) plans. Vestwell removes traditional friction points through a seamless plan design, automated onboarding, streamlined administration, and flexible investment strategies, all at competitive pricing. By acting as a single point of contact, Vestwell has modernized the retirement offering while keeping the plan sponsor’s and plan participant’s best interests in mind. Learn more at www.vestwell.com.\n\nWarmly is the first AI-fueled pipeline acceleration platform that harnesses the power of existing sales enablement and intent tools to automatically identify high propensity website visitors and alert them to sales for real-time engagement. It’s the first such solution purpose built to meet the business and budget needs of SMBs. Learn more at www.warmly.ai.\n\nWintermute is a global algorithmic liquidity provider for digital assets. Wintermute’s mission is to create liquid, efficient and transparent markets for institutional and retail investors across all vetted trading platforms and its own RFQ platform. Founded and managed by experienced traders and engineers from traditional financial markets, Wintermute brings the best practices of algorithmic and high-frequency trading into digital asset markets. Learn more at www.wintermute.com.\n\nXaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Learn more at www.xaira.com.\n\nCreating the industry’s first shared development platform backed by a shared data record, Zus aims to bring about a better health data reality by empowering a wave of new, digital-first healthcare builders who will create digital health technologies and services that are cheaper, more customizable, and more personalized. This vision drives Zus to proactively connect the largest array of traditional medical providers to novel health data sources so that health data becomes frictionless to use. Learn more at www.zushealth.com."
    }
}